BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28472490)

  • 21. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test.
    Gutierrez-Galhardo MC; Zancopé-Oliveira RM; Monzón A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Mycoses; 2010 May; 53(3):227-31. PubMed ID: 19389067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sporotrichosis caused by Sporothrix brasiliensis in Argentina: Case report, molecular identification and in vitro susceptibility pattern to antifungal drugs.
    Etchecopaz AN; Lanza N; Toscanini MA; Devoto TB; Pola SJ; Daneri GL; Iovannitti CA; Cuestas ML
    J Mycol Med; 2020 Apr; 30(1):100908. PubMed ID: 31732417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii.
    Zhang X; Huang H; Feng P; Zhang J; Zhong Y; Xue R; Xie Z; Li M; Xi L
    Eur J Dermatol; 2011; 21(4):573-6. PubMed ID: 21865116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole].
    Meinerz AR; Nascente Pda S; Schuch LF; Cleff MB; Santin R; Brum Cda S; Nobre Mde O; Meireles MC; Mello JR
    Rev Soc Bras Med Trop; 2007; 40(1):60-2. PubMed ID: 17486256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.
    Kohler LM; Monteiro PC; Hahn RC; Hamdan JS
    J Clin Microbiol; 2004 Sep; 42(9):4319-20. PubMed ID: 15365033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporotrichosis Caused by Non-Wild Type
    Bernardes-Engemann AR; Tomki GF; Rabello VBS; Almeida-Silva F; Freitas DFS; Gutierrez-Galhardo MC; Almeida-Paes R; Zancopé-Oliveira RM
    Front Cell Infect Microbiol; 2022; 12():893501. PubMed ID: 35694546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
    Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles.
    Alves SH; Boettcher CS; Oliveira DC; Tronco-Alves GR; Sgaria MA; Thadeu P; Oliveira LT; Santurio JM
    Rev Soc Bras Med Trop; 2010; 43(5):523-5. PubMed ID: 21085862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporotrichosis in dogs: epidemiological and clinical-therapeutic profile and the emergence of itraconazole-resistant isolates.
    Baes Pereira S; Dos Reis Gomes A; Bressan Waller S; Batista Xavier JR; Messias Rodrigues A; Kutscher Ripoll M; Ferreira MRA; Rochedo Conceição F; Osório de Faria R; Pascoti Bruhn FR
    Med Mycol; 2022 Dec; 60(12):. PubMed ID: 36455616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds.
    Ramos MLM; Almeida-Silva F; de Souza Rabello VB; Nahal J; Figueiredo-Carvalho MHG; Bernardes-Engemann AR; Poester VR; Xavier MO; Meyer W; Zancopé-Oliveira RM; Frases S; Almeida-Paes R
    Braz J Microbiol; 2024 Jun; 55(2):1359-1368. PubMed ID: 38466550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Alvarado-Ramírez E; Torres-Rodríguez JM
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2420-3. PubMed ID: 17438048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
    McGinnis MR; Nordoff N; Li RK; Pasarell L; Warnock DW
    Med Mycol; 2001 Aug; 39(4):369-71. PubMed ID: 11556767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jabuticaba [
    Waller SB; Peter CM; Hoffmann JF; Cleff MB; Faria de RO; Zani JL
    Nat Prod Res; 2021 Dec; 35(24):5988-5992. PubMed ID: 32840143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis.
    Ishida K; Castro RA; Torrado JJ; Serrano DR; Borba-Santos LP; Quintella LP; de Souza W; Rozental S; Lopes-Bezerra LM
    Med Mycol; 2018 Apr; 56(3):288-296. PubMed ID: 28575449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sporothrix schenckii COMPLEX:SUSCEPTIBILITIES TO COMBINED ANTIFUNGAL AGENTS AND CHARACTERIZATION OF ENZYMATIC PROFILES.
    Oliveira DC; de Loreto ÉS; Mario DA; Lopes PG; Neves LV; da Rocha MP; Santurio JM; Alves SH
    Rev Inst Med Trop Sao Paulo; 2015; 57(4):289-94. PubMed ID: 26422151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline for the management of feline sporotrichosis caused by Sporothrix brasiliensis and literature revision.
    Gremião IDF; Martins da Silva da Rocha E; Montenegro H; Carneiro AJB; Xavier MO; de Farias MR; Monti F; Mansho W; de Macedo Assunção Pereira RH; Pereira SA; Lopes-Bezerra LM
    Braz J Microbiol; 2021 Mar; 52(1):107-124. PubMed ID: 32990922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference of melanin in the susceptibility profile of Sporothrix species to amphotericin B.
    Mario DA; Santos RC; Denardi LB; Vaucher Rde A; Santurio JM; Alves SH
    Rev Iberoam Micol; 2016; 33(1):21-5. PubMed ID: 26194334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Sporothrix activity of ibuprofen combined with antifungal.
    Borba-Santos LP; Nucci M; Ferreira-Pereira A; Rozental S
    Braz J Microbiol; 2021 Mar; 52(1):101-106. PubMed ID: 32617835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
    Lin L; Huang J; Fang J; Li J; Cai W; Zhang J; Lu S
    Mycoses; 2023 Aug; 66(8):651-658. PubMed ID: 37156262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coinfection of domestic felines by distinct Sporothrix brasiliensis in the Brazilian sporotrichosis hyperendemic area.
    Macêdo-Sales PA; Souza LOP; Della-Terra PP; Lozoya-Pérez NE; Machado RLD; Rocha EMDSD; Lopes-Bezerra LM; Guimarães AJ; Rodrigues AM; Mora-Montes HM; Santos ALSD; Baptista ARS
    Fungal Genet Biol; 2020 Jul; 140():103397. PubMed ID: 32325170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.